Mark G. Currie
2012
In 2012, Mark G. Currie earned a total compensation of $1.3M as Senior Vice President, Chief Scientific Officer and President of R&D at Ironwood Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $104,139 |
|---|---|
| Option Awards | $809,842 |
| Salary | $365,400 |
| Other | $7,440 |
| Total | $1,286,821 |
Currie received $809.8K in option awards, accounting for 63% of the total pay in 2012.
Currie also received $104.1K in non-equity incentive plan, $365.4K in salary and $7.4K in other compensation.
Rankings
In 2012, Mark G. Currie's compensation ranked 5,145th out of 11,487 executives tracked by ExecPay. In other words, Currie earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,145 out of 11,487 | 55th |
Division Manufacturing | 1,795 out of 4,253 | 58th |
Major group Chemicals And Allied Products | 430 out of 1,198 | 64th |
Industry group Drugs | 281 out of 920 | 70th |
Industry Pharmaceutical Preparations | 221 out of 700 | 68th |
Source: SEC filing on April 17, 2015.
Currie's colleagues
We found three more compensation records of executives who worked with Mark G. Currie at Ironwood Pharmaceuticals in 2012.